Anti human msh6 clone bc 44

Manufactured by Biocare Medical

Sourced in Canada

The Anti-human MSH6 (clone BC/44) is a primary antibody used for the detection of the MSH6 protein in biological samples. MSH6 is a DNA mismatch repair protein that is involved in the maintenance of genomic stability. This antibody can be used in various laboratory techniques, such as immunohistochemistry and Western blotting, to study the expression and localization of the MSH6 protein.

Automatically generated - may contain errors

Lab products found in correlation

Mouse anti human mlh1 clone g168 15, by Biocare Medical (2 mentions) Anti human msh2 clone fe11, by Biocare Medical (2 mentions)

Close spelling variants of this product

MSH6 (clone BC/44;

2 protocols using anti human msh6 clone bc 44

Immunohistochemical Assessment of MMR Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols

MMR protein (MLH1, MSH2 and MSH6) expression was analyzed in formalin-fixed, paraffin-embedded tumor sections using an immunoperoxidase method (27 (link)). Monoclonal antibodies included mouse anti-human MLH1 (clone G168-15, Biocare Medical, Concord, CA), anti-human MSH2 (clone FE11, Biocare Medical, Concord, CA), and anti-human MSH6 (clone BC/44; Biocare Medical, Concord, CA). MMR protein loss was defined as the absence of nuclear staining in tumor cells in the presence of positive nuclear staining in normal colonic epithelium and lymphocytes. Tumors were classified as MMR-deficient (vs MMR-proficient) if loss of one or more MMR proteins was detected.

Yoon H.H., Tougeron D., Shi Q., Alberts S.R., Mahoney M.R., Nelson G.D., Nair S.G., Thibodeau S.N., Goldberg R.M., Sargent D.J, & Sinicrope F.A. (2014). KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild type stage III colon cancers from an adjuvant chemotherapy trial (N0147 Alliance). Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 3033-3043.

+ Open protocol

+ Expand

Immunohistochemical Analysis of MMR Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols

MMR protein (MLH1, MSH2 and MSH6) expression was analyzed in formalin-fixed, paraffin-embedded tumor sections as previously described (19 (link)). Monoclonal antibodies included mouse anti-human MLH1 (clone G168-15, Biocare Medical, Concord, CA), anti-human MSH2 (clone FE11, Biocare), and anti-human MSH6 (clone BC/44; Biocare). MMR protein loss was defined as the absence of nuclear staining in tumor cells in the presence of nuclear staining in normal colonic epithelium and lymphocytes. Tumors were categorized as deficient (d) vs proficient (p) MMR if loss of at least one MMR protein was detected.

Sinicrope F.A., Mahoney M.R., Yoon H.H., Smyrk T.C., Thibodeau S.N., Goldberg R.M., Nelson G.D., Sargent D.J, & Alberts S.R. (2015). Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance). Clinical cancer research : an official journal of the American Association for Cancer Research, 21(23), 5294-5304.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!